Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis

Roni Nowarski, Ruaidhri Jackson, Nicola Gagliani, Marcel R. de Zoete, Noah W. Palm, Will Bailis, Jun Siong Low, Christian C. D. Harman, Morven Graham, Eran Elinav, Richard A. Flavell

Research output: Contribution to journalArticlepeer-review


The intestinal mucosal barrier controlling the resident microbiome is dependent on a protective mucus layer generated by goblet cells, impairment of which is a hallmark of the inflammatory bowel disease, ulcerative colitis. Here, we show that IL-18 is critical in driving the pathologic breakdown of barrier integrity in a model of colitis. Deletion of Il18 or its receptor Il18r1 in intestinal epithelial cells (D/EC) conferred protection from colitis and mucosal damage in mice. In contrast, deletion of the IL-18 negative regulator Il18bp resulted in severe colitis associated with loss of mature goblet cells. Colitis and goblet cell loss were rescued in Il18bp(-/-);Il18r(Delta/EC) mice, demonstrating that colitis severity is controlled at the level of IL-18 signaling in intestinal epithelial cells. IL-18 inhibited goblet cell maturation by regulating the transcriptional program instructing goblet cell development. These results inform on the mechanism of goblet cell dysfunction that underlies the pathology of ulcerative colitis.
Original languageEnglish
Pages (from-to)1444-1456
Number of pages13
Issue number6
StatePublished - 6 Dec 2015


Dive into the research topics of 'Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis'. Together they form a unique fingerprint.

Cite this